Signatur Biosciences
Simple tests for complex diseases.
About Signatur Biosciences
Simple tests for complex diseases.
Open positions (1)
Company details
Funding
Total raised
$9.9M
Last stage
Seed
Investors
Founders
Dr. John Goertz
Bioengineer who met co-founder Celestin de Wergifosse while studying at Imperial College London; co-founded Signatur Biosciences in 2022.
Dame Molly Stevens
World-renowned materials scientist and professor at Imperial College London/University of Oxford whose Stevens Group research spun out into Signatur Biosciences.
John Goertz
Co-founder, CSO, and PCRchitect at Signatur Biosciences. I teach machine learning to molecules to expand the range of diseases we can diagnose with PCR. NIH F32 Postdoctoral Fellow in the the Stevens Group at Imperial College London; PhD Bioengineering from University of Maryland, College Park; BSc Physics and Cell & Molecular Biology from Seattle University. When I’m not programming DNA, I’m cooking, running, or doing martial arts (Danzan-Ryu Japanese Jujitsu).
LinkedInCelestin de Wergifosse
Co-founder and CEO of Signatur Biosciences. Startups since the age of 14. First patent at 15. WIPO Best Young Inventor 2010. Twice TEDx speaker. Co-founded Young Change Maker, a social startup that highlights inspiring individuals. Co-founded and sold a company called Sauna en Bois. Bio-engineering from Imperial College London. When I don't work, I race motorcycles, climb or ski. My life-long goal is to develop biotech companies that address global issues.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.
